SHROTRIYA RAJESH C MD 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed May 14, 2018
Insider Transaction Report
Form 4
SHROTRIYA RAJESH C MD
DirectorChairman, CEO & President
Transactions
- Sale
Common Stock, $0.001 par value
2018-05-10$17.13/sh−30,000$513,900→ 669,977 total(indirect: By Trust) - Sale
Common Stock, $0.001 par value
2018-05-11$17.55/sh−30,000$526,500→ 639,977 total(indirect: By Trust) - Sale
Common Stock, $0.001 par value
2018-05-14$18.38/sh−24,014$441,377→ 615,963 total(indirect: By Trust)
Holdings
- 1,787,542(indirect: By Trust)
Common Stock, $0.001 par value
- 1,243,284(indirect: By Trust)
Common Stock, $0.001 par value
- 28,907(indirect: By 401(k))
Common Stock, $0.001 par value
- 9,523(indirect: By Spouse)
Common Stock, $0.001 par value
- 67,144(indirect: By Foundation)
Common Stock, $0.001 par value
- 200,652
Common Stock, $0.001 par value
Footnotes (4)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.25, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.81, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.075 to $18.50, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.